deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL NCT00916981

Treatment of Atrophic Nonunion by Preosteoblast Cells

Treatment of Refractory Non-union Fractures by Pre-osteoblast Cells Grafting : a Pilot Study.

Sponsor: Jean-Philippe Hauzeur

Updated 7 times since 2017 Last updated: Feb 22, 2012 Started: Nov 30, 2008 Primary completion: Jun 30, 2009 Completion: Jun 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Fractures, Ununited and Pseudarthrosis, this trial is completed. The trial is conducted by Jean-Philippe Hauzeur and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotCompleted~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Jun 2019 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

Show 2 earlier versions
  1. Jun 2018 — Jun 2019 [monthly]

    Completed PHASE1_PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jean-Philippe Hauzeur
Data source: University of Liege

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations